| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Hiroshima University School of Medicine, Kasumi 1-2-3, Minami-ku, Hiroshima 734, Japan
This study deals with the growth effect of gastrin on two xenotransplantable human gastric carcinomas (SC-6-JCK, poorly differentiated adenocarcinoma; and St-15, mucinous adenocarcinoma) and on one colonic carcinoma (Co-3, well-differentiated adenocarcinoma). In SC-6-JCK, the treatment with s.c. injection of pentagastrin at a dose of 10 µg/mouse once daily for 25 days promoted the growth of the tumor transplanted in nude mice, but gastrin had no effect at all on St-15 and Co-3. In SC-6-JCK, the weight, size, and labeling index of [3H]thymidine of the tumor were significantly increased in comparison with those of the control (p < 0.05).
In SC-6-JCK, cyclic adenosine 3':5'-monophosphate (cAMP) in the tumor was increased by a single i.p. injection of pentagastrin at a dose of 20 µg/mouse in nude mice, but such an increase was not observed in St-15 and Co-3. Cyclic guanosine 3':5'-monophosphate in SC-6-JCK was slightly increased by gastrin treatment but was not affected in the other tumors. In SC-6-JCK, at 30 min after gastrin treatment when cAMP showed a maximum increase, the activity ratio of cAMP-dependent protein kinase in the tumor was also elevated. In vitro also, gastrin stimulated cAMP production and cAMP-dependent protein kinase activation. The data suggest that some human gastric carcinomas may have receptor for gastrin.
1 Supported in part by grants-in-aid for cancer research from the Ministry of Education, Science, and Culture (58010070, 58015078).
2 To whom requests for reprints should be addressed.
Received 2/22/84. Accepted 6/14/84.
This article has been cited by other articles:
![]() |
R. P. Thomas, M. R. Hellmich, C. M. Townsend Jr., and B. M. Evers Role of Gastrointestinal Hormones in the Proliferation of Normal and Neoplastic Tissues Endocr. Rev., October 1, 2003; 24(5): 571 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Smith and S A Watson Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence Gut, December 1, 2000; 47(6): 820 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Smith, T. Justin, D. Michaeli, and S. A. Watson Phase I/II Study of G17-DT, an Anti-Gastrin Immunogen, in Advanced Colorectal Cancer Clin. Cancer Res., December 1, 2000; 6(12): 4719 - 4724. [Abstract] [Full Text] |
||||
![]() |
Y. Konda, H. Kamimura, H. Yokota, N. Hayashi, K. Sugano, and T. Takeuchi Gastrin stimulates the growth of gastric pit with less-differentiated features Am J Physiol Gastrointest Liver Physiol, October 1, 1999; 277(4): G773 - G784. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, G.-y. Yang, W. Y. Ding, F. Bondoc, S. K. Curtis, and C. S. Yang An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload Carcinogenesis, September 1, 1999; 20(9): 1801 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
W F Heydens, A G. Wilson, L D Kier, H Lau, D C Thake, and M A Martens An evaluation of the carcinogenic potential of the herbicide alachlor4 to man Human and Experimental Toxicology, June 1, 1999; 18(6): 363 - 391. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |